Anti-Jo1 Antibody in Polymyositis/dermatomyositis Is Still Closely Associated with Lung rather than Joints

被引：4
|
作者：
Jearn, La-He
Kim, Think-You
机构：
[1] Hanyang Univ, Med Ctr, Div Diagnost Immunol, Seoul 133792, South Korea
[2] Hanyang Univ, Med Ctr, Dept Lab Med, Seoul 133792, South Korea
来源：
JOURNAL OF RHEUMATOLOGY | 2015年 / 42卷 / 06期
关键词：
DERMATOMYOSITIS; POLYMYOSITIS;
D O I：
10.3899/jrheum.141470
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1060 / 1060
页数：1
相关论文
共 50 条
  • [21] Nocardia pleural empyema complicating anti-Jo1 positive polymyositis during immunoglobulin and steroid therapy
    La Civita, L
    Battiloro, R
    Celano, M
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (01) : 215 - 216
  • [22] Squamous cell carcinoma of the lung associated with anti-Jo1 antisynthetase syndrome: a case report and review of the literature
    G. Boleto
    J.-M. Perotin
    J.-P. Eschard
    J.-H. Salmon
    Rheumatology International, 2017, 37 : 1203 - 1206
  • [23] Squamous cell carcinoma of the lung associated with anti-Jo1 antisynthetase syndrome: a case report and review of the literature
    Boleto, G.
    Perotin, J. -M.
    Eschard, J. -P.
    Salmon, J. -H.
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (07) : 1203 - 1206
  • [24] Pattern of Perifascicular involvement differentiates the anti-Jo1 inflammatory myopathy (IM) from dermatomyositis (DM)
    Chahin, N.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S248 - S248
  • [25] Nocardia pleural empyema complicating anti-Jo1 positive polymyositis during immunoglobulin and steroid therapy -: Reply
    Leong, KP
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (01) : 216 - 217
  • [26] Lung microbiome alterations in patients with anti-Jo1 antisynthetase syndrome and interstitial lung disease
    Quintero-Puerta, Teresa
    Lira-Lucio, Juan Alberto
    Falfan-Valencia, Ramces
    Vega-Sanchez, Angel E.
    Marquez-Garcia, Eduardo
    Mejia, Mayra
    Bautista-Becerril, Brandon
    Rojas-Serrano, Jorge
    Ramos-Martinez, Espiridion
    Buendia-Roldan, Ivette
    Perez-Rubio, Gloria
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [27] Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: A single centre study and review of the literature
    Ingegnoli, Francesca
    Lubatti, Chiara
    Ingegnoli, Anna
    Boracchi, Patrizia
    Zeni, Silvana
    Meroni, Pier Luigi
    AUTOIMMUNITY REVIEWS, 2012, 11 (05) : 335 - 340
  • [28] Anti-glycyl tRNA synthetase antibody associated interstitial lung disease without symptoms of polymyositis/dermatomyositis
    Hara, Yuki
    Tanaka, Tomonori
    Tabata, Kazuhiro
    Shiraki, Akira
    Hayashi, Kentaro
    Kashima, Yukio
    Hayashi, Tomayoshi
    Fukuoka, Junya
    PATHOLOGY INTERNATIONAL, 2014, 64 (03) : 148 - 150
  • [29] Focal and Patchy Perifasicular Involvement Differentiates the Anti-Jo1 Inflamatory Myopathy (IM) from Dermatomyositis (DM)
    Chahin, Nizar
    Karam, Chafic
    NEUROLOGY, 2016, 86
  • [30] D-PENICILLAMINE AND POLYMYOSITIS - THE SIGNIFICANCE OF THE ANTI-JO-1 ANTIBODY
    JENKINS, EA
    HULL, RG
    THOMAS, AL
    BRITISH JOURNAL OF RHEUMATOLOGY, 1993, 32 (12): : 1109 - 1110
12345